Abstract Submission

 

Deadline: September 29th, 2025 at 11:59 PM EST

If you have any questions about abstract submission, please email us at info@hepdart.com.

All accepted abstracts will be made available to conference delegates through the abstract booklet, available on the website, and in print on December 7, 2025.

Guidelines

  • Use Arial font size 10 for your abstract

  • Please include a title in bold at the top of the abstract, this should be followed by list of authors and affiliations

  • All submitted abstracts should consist of background, methods, results, and conclusions  

  • All text should flush to the left side of the page

  • Although there is no word limit to the abstract, we recommend a length of 500 words

  • If you choose to include figures, tables, or chemical structures in your abstract, please fit the abstract to one page (A4)

Please see below for an example of an abstract:

Screen Shot 2019-04-09 at 4.29.07 PM.png

Categories for abstract submission 

  • Global hepatitis epidemiology and prospects for elimination 

  • Access, cost, and treatment in special populations

  • Hepatitis B basic science 

  • Advances in therapeutics for HBV 

  • Curative strategies for HBV

  • Clinical advancements for HBV 

  • COVID-19 and liver disease 

  • Advances in therapeutics for MASH/MAFLD and HCC 

  • New developments in liver disease, NASH and biomarkers 

  • Diagnostics 

  • Advances in HCV therapy 

  • Advances in therapeutics for HDV

  • Immunity, vaccines and transplantation 

  • Hepatocellular carcinoma: New treatments and findings 

  • Hepatitis A, hepatitis E and other hepatitis viruses 

  • Viral hepatitis and co-infections with HIV and other viruses

  • Other Hepatitis or Liver related abstracts

 

Powerpoint Slides

There is not a template for slides, but we recommend a 16:9 widescreen format for best results.